Nsr Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-12-2024
- Paid Up Capital ₹ 0.10 M
as on 27-12-2024
- Company Age 5 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.99%
(FY 2022)
- Profit 97.26%
(FY 2022)
- Ebitda 102.24%
(FY 2022)
- Net Worth 34.70%
(FY 2022)
- Total Assets 98.29%
(FY 2022)
About Nsr Laboratories
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pavani Anantaneni and Sambasivarao Narukulla serve as directors at the Company.
- CIN/LLPIN
U51909TG2019PTC136221
- Company No.
136221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Oct 2019
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media
What products or services does Nsr Laboratories Private Limited offer?
Nsr Laboratories Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Fragrance Chemicals, Nutraceuticals & Dietary Supplements, Fitness Supplements, Medical Laboratory Instruments, VTM Kit Raw Materials, Industrial Chemicals, Organic and Inorganic Solvents, Carboxylate Esters.
Who are the key members and board of directors at Nsr Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pavani Anantaneni  | Director | 19-Oct-2019 | Current |
| Sambasivarao Narukulla | Director | 19-Oct-2019 | Current |
Financial Performance of Nsr Laboratories.
Nsr Laboratories Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.99% increase. The company also saw a substantial improvement in profitability, with a 97.26% increase in profit. The company's net worth Soared by an impressive increase of 34.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nsr Laboratories?
Unlock access to Nsr Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nsr Laboratories?
Unlock and access historical data on people associated with Nsr Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nsr Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nsr Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.